|

EGFR/B7H3 CAR-T Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • Second Affiliated Hospital of Guangzhou Medical University1

Indications

  • EGFR/ B7H3-positive Advanced Triple-negative Breast Cancer1
  • EGFR/ B7H3-positive Advanced Lung Cancer1
  • Lung Cancer1
  • Breast Cancer1
  • Cancer1

Other1 trial

EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.